Two CVOTs of tirzepatide are being conducted: SURPASS-CVOT (NCT04255433), which is targeting individuals with T2D and a history of CVD
Future research should prioritize elucidating the molecular mechanisms behind the antitumor effects, refining individualized treatment strategies, investigating early tumor prevention applications, assessing potential benefits for non-diabetic populations, advancing the development of novel therapies, establishing robust safety monitoring frameworks, and building precision medicine decision-making platforms
Understanding these trade-offs helps guide better decision-making
Nat Rev Endocrinol (2020) 16:6178
"Your body needs time to adjust and adapt." CLICK HERE TO DOWNLOAD THE FOX NEWS APP "You can go up if you hit a plateau or if it's not helping, but we usually wait a month to increase the dose." While many expect "instant gratification," health is about balance, Malhotra added
This triple agonism allows for an integrated modulation of key pathways regulating body weight and metabolic homeostasis